Home / Fact sheets / Italy / Cervical quantitative data
Country fact sheet: Italy (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 0 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 0 | 0 | 0 | 0 | |
Population (personally invited) | ||||||||||||||
Target population | 1509911 | 1615138 | 1852542 | 2238876 | 2404363 | 2449864 | 2185081 | 1961452 | 1891213 | 1713793 | 0 | 0 | 0 | 19 822 233 |
Annual target population | 0 | 538 379 | 617 514 | 746 292 | 801 454 | 816 621 | 728 360 | 653 817 | 630 404 | 0 | 0 | 0 | 0 | 5 532 841 |
Women invited | 26707 | 388775 | 376789 | 468963 | 530902 | 547511 | 498894 | 417611 | 381910 | 14143 | 0 | 0 | 41194 | 3 693 399 |
Invitation coverage (%) | 0.0 | 72.2 | 61.0 | 62.8 | 66.2 | 67.0 | 68.5 | 63.9 | 60.6 | 0.0 | 0.0 | 0.0 | 0.0 | 66.8 |
Examinations | ||||||||||||||
Women screened | 8 826 | 138 973 | 140 891 | 189 198 | 225 647 | 235 261 | 214 416 | 181 773 | 163 248 | 5 872 | 0 | 0 | 29 510 | 1 533 615 |
Examination coverage rate (%) | 33.0 | 35.7 | 37.4 | 40.3 | 42.5 | 43.0 | 43.0 | 43.5 | 42.7 | 41.5 | 0.0 | 0.0 | 71.6 | 41.5 |
Result (A subset of tests) | ||||||||||||||
Subset women screened | 8 130 | 136 779 | 137 086 | 174 426 | 207 444 | 213 023 | 191 625 | 157 549 | 142 934 | 7 139 | 0 | 0 | 25 816 | 1 401 951 |
Positive | 478 | 6 655 | 5 223 | 5 349 | 5 851 | 5 450 | 3 843 | 1 918 | 1 182 | 78 | 0 | 0 | 672 | 36 699 |
Negative | 7 652 | 130 124 | 131 863 | 169 077 | 201 593 | 207 573 | 187 782 | 155 631 | 141 752 | 7 061 | 0 | 0 | 25 144 | 1 365 252 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Referral for further assessment (%) | 5.9 | 4.9 | 3.8 | 3.1 | 2.8 | 2.6 | 2.0 | 1.2 | 0.8 | 1.1 | 0.0 | 0.0 | 2.6 | 2.6 |
Further assessment (a subset of positive) | ||||||||||||||
Subset positive tests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36 669 | 36 669 |
Done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 148 | 32 148 |
Not done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 521 | 4 521 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Further assessment participation rate (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 87.7 | 87.7 |
Outcome (subset of tests) | ||||||||||||||
Subset of women screened | 0 | 8 130 | 132 641 | 136 716 | 173 800 | 206 454 | 212 279 | 190 874 | 156 903 | 142 531 | 7 129 | 0 | 32 172 | 1 399 629 |
No biopsy performed, no CIN nor ca detected | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 116 | 19 116 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 279 | 279 |
Carcinoma | 0 | 1 | 11 | 17 | 27 | 31 | 28 | 31 | 17 | 12 | 2 | 0 | 9 | 186 |
CIN3 / Adenocarcinoma in situ (CGIN) | 0 | 14 | 423 | 427 | 471 | 375 | 294 | 182 | 105 | 41 | 3 | 0 | 41 | 2 376 |
CIN2 | 0 | 15 | 515 | 424 | 397 | 347 | 258 | 164 | 87 | 44 | 2 | 0 | 21 | 2 274 |
CIN1 | 0 | 69 | 1 452 | 955 | 884 | 936 | 788 | 482 | 225 | 110 | 4 | 0 | 65 | 5 970 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 0 | -99 | -2 401 | -1 823 | -1 779 | -1 689 | -1 368 | -859 | -434 | -207 | -11 | 0 | 12 617 | 1 947 |